Peter Joseph Imbornone

Peter Joseph Imbornone ( PETER JOSEPH IMBORNONE ) is A Internal Medicine Physician in Rochelle Park, NJ. The NPI Number for Peter Joseph Imbornone is 1568531432.

The current location address for Peter Joseph Imbornone is 96 PARKWAY ROCHELLE PARK MEDICAL CENTER PA Rochelle Park, NJ 07662 and the contact number is 2012911010 and fax number is 2015870313. The mailing address for Peter Joseph Imbornone is 96 PARKWAY ROCHELLE PARK MEDICAL CENTER PA Rochelle Park, NJ 07662- 2012911010 (mailing address contact number - 2012911010).

A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.

What is the NPI Number for Peter Joseph Imbornone ?

Answer: The NPI Number for Peter Joseph Imbornone is 1568531432

Where is Peter Joseph Imbornone located?

Answer: Peter Joseph Imbornone is located at 96 PARKWAY ROCHELLE PARK MEDICAL CENTER PA Rochelle Park, NJ 07662.

What is the specialty for Peter Joseph Imbornone ?

Answer: The Specialty of Peter Joseph Imbornone is A Internal Medicine Physician.

Are there any online reviews for Peter Joseph Imbornone ?

Answer: Yes! Check It Now.

Are there any other health care providers in Rochelle Park, NJ?

Answer: Yes, there are given below...

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Internal Medicine
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	215
Number of Standardized 30-Day Fills	433.96666667
Aggregate Cost Paid for All Claims	14152.25
Number of Day's Supply for All Claims	12883
Number of Medicare Beneficiaries	77
Number of Claims, Including Refills, for Beneficiaries Age 65+
Including Refills, for Beneficiaries Age 65+
Beneficiaries Age 65+
Number of Day's Supply for All Claims for Beneficaries Age 65+
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst	#
Total Claims of Brand-Name Drugs
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills	192
Aggregate Cost Paid for Generic Drugs	6169.09
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst	*
Total Claims of Other Drugs, Including Refills
Aggregate Cost Paid for Other Drugs
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans	21
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans	2540.58
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans	194
Aggregate Cost Paid for Claims Filled by	11611.67
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst
Number of Claims for Beneficiaries Covered by Low-Income Subsidy	75
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy	2010.21
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy	140
by Low-Income Subsidy	12142.04
Total Claims of Opioid Drugs, Including	0
Aggregate Cost Paid for Opioid Drugs	0
Opioid Claims	0
Opioid_Tot_Clms divided by the Tot_Clms	0
Total Claims of Long-Acting Opioid Drugs	0
Aggregate Cost Paid for Long-Acting Opioid	0
Number of Day's Supply of All Long-Acting	0
Long-Acting Opioid Claims	0
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including
Aggregate Cost Paid for Antibiotic Drugs
Antibiotic Claims
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst	*
Including Refills, for Beneficiaries Age 65+
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries	76.883116883
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries	42
Number of Male Beneficiaries	35
Number of Non-Hispanic White	66
Number of Black or African American
Number of Asian Pacific Islander
Number of Hispanic Beneficiaries
Number of American Indian/Alaskan NativeBeneficiaries	0
Number of Beneficiaries with Race Not
Only Entitlement
Average Hierarchical Condition Category	1.0297642925